RT Journal Article
SR Electronic
T1 Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004699
DO 10.1136/jitc-2022-004699
VO 10
IS 4
A1 Nguyen, Lee S
A1 Bretagne, Marie
A1 Arrondeau, Jennifer
A1 Zahr, Noel
A1 Ederhy, Stephane
A1 Abbar, Baptiste
A1 Pinna, Bruno
A1 Allenbach, Yves
A1 Mira, Jean-Paul
A1 Moslehi, Javid
A1 Rosenzwajg, Michelle
A1 Salem, Joe-Elie
YR 2022
UL http://jitc.bmj.com/content/10/4/e004699.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.